Fig. 3

Kaplan–Meier curves represent survival of HCM patients who were free of adverse clinical events. Participants with A LA diameter of more than or equal to 57 mm, B LAV pre-ac of more than or equal to 85 ml, C passive LAEF of less than or equal to 9.6%, D LA GLS booster of less than or equal to 8.9%, and E LV SV of less than or equal to 83.4 ml displayed significantly higher risk of adverse clinical events. LA, left atrium; LAV, left atrial volume; pre-ac, pre-contraction; LAEF, left atrial ejection fraction; GLS, global longitudinal strain; LV, left ventricular; SV, stroke volume